Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biosyent Inc BIOYF


Primary Symbol: V.RX

Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Recent & Breaking News (TSXV:RX)

BioSyent Schedules Q1 2018 Earnings Release for May 30, 2018

GlobeNewswire May 17, 2018

FeraMAX® Named #1 by Canadian Physicians and Pharmacists for Third Consecutive Year

GlobeNewswire May 1, 2018

BioSyent Releases Results for Fourth Quarter and Full Year 2017

GlobeNewswire March 21, 2018

BioSyent Schedules Fourth Quarter 2017 Earnings Release for March 21, 2018

GlobeNewswire March 8, 2018

BioSyent Announces Changes to Its Board of Directors

GlobeNewswire January 8, 2018

BioSyent Releases Results for Third Quarter and First Nine Months of 2017

GlobeNewswire November 15, 2017

BioSyent Schedules Q3 2017 Earnings Release for November 15, 2017

GlobeNewswire November 8, 2017

BioSyent Named to the PROFIT 500 Ranking of Canada’s Fastest-Growing Companies for Fifth Consecutive Year

GlobeNewswire September 14, 2017

BioSyent Releases Q2 and H1 2017 Results - CORRECTION

GlobeNewswire August 16, 2017

BioSyent Releases Q2 and H1 2017 Results

GlobeNewswire August 16, 2017

BioSyent Schedules Q2 and H1 2017 Earnings Release for August 16, 2017

GlobeNewswire August 8, 2017

RBC Global Asset Management Inc. announces RBC ETF cash distributions for June 2017

Canada NewsWire June 15, 2017

BioSyent Releases Q1 2017 Results

MarketWire Canada May 25, 2017

BioSyent Schedules Q1 2017 Earnings Release for May 25, 2017

Marketwired May 16, 2017

FeraMAX(R) Named #1 by Canadian Physicians and Pharmacists for Second Consecutive Year

Marketwired May 1, 2017

BioSyent to Present at 2017 Bloom Burton & Co. Healthcare Investor Conference

MarketWire Canada April 24, 2017

BioSyent Extends In-License Agreement for Cathejell(R)

Marketwired April 20, 2017

BioSyent Releases Results for Fourth Quarter and Full Year 2016

MarketWire Canada March 15, 2017

BioSyent Schedules Fourth Quarter 2016 Earnings Release for March 15, 2017

Marketwired March 6, 2017

BioSyent Announces Sale of Shares

MarketWire Canada December 12, 2016